Steven Michael Joins BioAgilytix as SVP, Bioanalytical Operations

BioAgilytix, a leading provider of contract bioanalytical services, announced today that Steven M. Michael, Ph.D., has joined BioAgilytix as a member of the executive team in a newly created role, Senior Vice President of Bioanalytical Operations.  Reporting to President and Chief Executive Officer, Jim Datin, Steve will have oversight of the strategic direction, expansion, and scientific operations at BioAgilytix. 

“I am thrilled that Steve will be joining our team,” said Datin.  “He shares our values and has an outstanding track record managing global businesses and driving growth.  As a 20-year industry veteran, Steve brings a powerful combination of scientific expertise and business acumen.  His leadership as both an industry provider and customer has proven his ability to scale operations, facilities, and people in order to meet growing demand and customer needs.”

“I am honored to join BioAgilytix and look forward to working as a part of the team,” said Michael.  I have long admired BioAgilytix’s quality-focused approach to bioanalytical testing and I believe the company is well positioned for future growth.”

Steve has joined BioAgilytix after five years with Covance, where he served in a number of executive roles, lastly as Vice President, Global Drug Metabolism & Pharmacokinetics, DMPK.  Previously he worked for pharmaceutical powerhouse Pfizer in various capacities including Executive Director, Bioanalytical Research and Compliance.  His pharmaceutical industry experience includes drug discovery, drug development, and research technology with a focus on bioanalytical research, translational research, biomarkers, and leadership development. 

Learn More About Steve.

About BioAgilytix www.bioagilytix.com

BioAgilytix is a leading bioanalytical testing laboratory specializing in large-molecule bioanalysis.  Located in North Carolina’s Research Triangle, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assays services supporting the development and release testing of biologics and small molecule therapeutics. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, and GLP, as well as product release testing under GMP.

BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, sample and data integrity, and regulatory compliance through all phases of clinical development, acting as a trusted partner to 6 of the top 10 global pharmaceutical and biotech companies.

###

Media Contact:

Matthew Hoyle, Marketing Manager
BioAgilytix
(919) 908-8032
[email protected]

Cell-Based Assays

Learn how BioAgilytix provides the specialized large molecule insight and proven GLP / GMP knowledge needed to support a full range of cell-based assay (CBA) requirements.

Pharmacokinetics (PK) Services

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.

SPEAK TO A SCIENTIST

Cell-Based Assays

Learn how BioAgilytix provides the specialized large molecule insight and proven GLP / GMP knowledge needed to support a full range of cell-based assay (CBA) requirements.

Pharmacokinetics (PK) Services

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.

SPEAK TO A SCIENTIST
Share This